The World Bank Group welcomes the publication of the new Global Burden of Disease Study (GBD). The Bank commissioned the fi rst GBD in 1990, and continues to make extensive use of this signal contribution to global health. Like its predecessors, the new, methodologically updated GBD 2010 marks a milestone in global health knowledge and our capacity for evidence-based action. It will once again ...

BACKGROUND Pneumonia and diarrhea are leading causes of death for children under five (U5). It is challenging to estimate the total number of deaths and cause-specific mortality fractions. Two major efforts, one led by the Institute for Health Metrics and Evaluation (IHME) and the other led by the World Health Organization (WHO)/Child Health Epidemiology Reference Group (CHERG) created estimate...

BACKGROUND The World Health Organization (WHO) has set ambitious time-bound targets for the control and elimination of neglected tropical diseases (NTDs). Investing in NTDs is not only seen as good value for money, but is also advocated as a pro-poor policy since it would improve population health in the poorest populations. We studied the extent to which the disease burden from nine NTDs (lymp...

The recently published Global Burden of Disease Study 2010 (GBD 2010) contains accurate, contemporary estimates of human morbidity and mortality, with substantial changes in the patterns of illness observed over the last two decades. One of the most significant alterations to these estimates has been the recognition that viral hepatitis is a leading cause of human mortality, with an estimated 1...

BACKGROUND Leishmaniasis covers a range of clinical manifestations. Estimation of the burden of leishmaniasis may help guide healthcare management personnel and policy-makers in applying effective interventions. The present study aimed to calculate the incidence and burden of cutaneous and visceral leishmaniasis in Iran in 2013. METHODS To evaluate the epidemiological aspects of the disease i...

BACKGROUND Current methods of measuring the population burden of injuries rely on many assumptions and limited data available to the global burden of diseases (GBD) studies. The aim of this study was to compare the population burden of injuries using different approaches from the UK Burden of Injury (UKBOI) and GBD studies. METHODS AND FINDINGS The UKBOI was a prospective cohort of 1,517 inju...

Studies on the Global Burden of Disease (GBD) and its risk factors have shown worldwide preponderant role accidents violence in burden disease alcohol consumption as a main factor current epidemiological profile (GBD 2019 Risk Factors Collaborators, 2020; GBD Diseases Injuries 2020). studies Mexico not only confirmed this (Gómez-Dantés et al., 2016), but also enormous human loss entailed by fac...

The Global Burden of Disease (GBD) Study 2010 estimated the GBD attributable to 15 categories of skin disease from 1990 to 2010 for 187 countries. For each of the following diseases, we performed systematic literature reviews and analyzed resulting data: eczema, psoriasis, acne vulgaris, pruritus, alopecia areata, decubitus ulcer, urticaria, scabies, fungal skin diseases, impetigo, abscess, and...

Like traffic jams and cell phones, particulate air pollution is a reality of modern living. Whether it’s from cigarette smoking, industrial emissions, or the burning of wood and dung for fuel, fine particulate matter (PM2.5) has been strongly linked to cardiovascular disease, inflammation, lung cancer, and other lung diseases. As part of the Global Burden of Disease Study (GBD) 2010 collaborati...

disease attributable to individual risk factors were calculated, as described in chapter 25, using risk factor exposure and hazard estimates provided in risk factor chapters. Mortality and burden of disease attributable to individual risk factors were then calculated by multiplying the PAFs by the estimates of total mortality and burden of disease from the Global Burden of Disease (GBD) databas...